CERo Therapeutics Holdings, Inc entered into a purchase agreement with Arena Business Solutions Global SPC II, Ltd, pursuant to the agreement the company has agreed to issue common stock for proceeds of $25 million on February 23, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.154 USD | +1.62% | -6.19% | -89.51% |
Apr. 02 | CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-89.51% | 16.72M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- CERo Therapeutics Holdings, Inc. announced that it expects to receive $25 million in funding from Arena Business Solutions Global SPC II, Ltd.